Studies of Human Amebiasis

Human Amebiasis: Breaking the Paradigm?

For over 30 years it has been established that the Entamoeba histolytica protozoan included two biologically and genetically different species, one with a pathogenic phenotype called E. histolytica and the other with a non-pathogenic phenotype called Entamoeba dispar. Both of these amoebae species can infect humans. E. histolytica has been considered as a potential pathogen that can cause serio...

Hepatic amebiasis.

Amebiasis can be considered the most aggressive disease of the human intestine, responsible in its invasive form for clinical syndromes, ranging from the classic dysentery of acute colitis to extra-intestinal disease, with emphasis on hepatic amebiasis, unsuitably named amebic liver abscess. Found worldwide, with a high incidence in India, tropical regions of Africa, Mexico and other areas of C...

Laboratory diagnosis of amebiasis.

The detection of Entamoeba histolytica, the causative agent of amebiasis, is an important goal of the clinical microbiology laboratory. To assess the scope of E. histolytica infection, it is necessary to utilize accurate diagnostic tools. As more is discovered about the molecular and cell biology of E. histolytica, there is great potential for further understanding the pathogenesis of amebiasis...

Some Modern Conceptions of Amebiasis.

studies on extraintestinal amebiasis in iran by serologic methods

sera from ninety one patients clinically suspected to extra intestinal amoebiasis (ex-am) were collected and examined for presence of anti entamoeba histolytica (e.h) antibody. the tests were indirect immunofluorescence antibody, (ifa or iif), gel diffusion (gd) and counter immuno electrophoresis (ciep). thirty one patients (34%) had anti e.h. antibody titres of >1:80. among them eight patients...